LIS
AMPH icon

Legacy Investment Solutions’s Amphastar Pharmaceuticals AMPH Stock Holding History

Legacy Investment Solutions’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$230 Buy
+10
New +$248 ﹤0.01% 699
2024
Q4 		$324 Hold
10
– – ﹤0.01% 692
2024
Q3 		$455 Buy
+10
New +$439 ﹤0.01% 620

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Legacy Investment Solutions's AMPH Position: Q2 2025 in Review

Legacy Investment Solutions opened a new position in Amphastar Pharmaceuticals (AMPH) in Q2 2025: 10 shares worth $230. The stake represents ﹤0.01% of the portfolio and ranks #699 among its holdings. This is a return to the name: Legacy Investment Solutions previously reported a position in AMPH as recently as Q4 2024.

Legacy Investment Solutions first reported a position in AMPH in Q3 2024 and has held it in 3 quarters since. The position peaked at $455 in Q3 2024. 245 funds tracked by Wall St. Rank hold AMPH as of Q2 2025.

  • Legacy Investment Solutions held 10 shares of Amphastar Pharmaceuticals worth $230 as of Q2 2025.
  • Amphastar Pharmaceuticals was a new Legacy Investment Solutions position in Q2 2025.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Legacy Investment Solutions's portfolio in Q2 2025, its #699 holding.
  • Legacy Investment Solutions first reported a position in Amphastar Pharmaceuticals in Q3 2024 and has held it in 3 quarters since.
  • Legacy Investment Solutions's Amphastar Pharmaceuticals position peaked at $455 in Q3 2024.
  • 245 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2025.

Based on Legacy Investment Solutions's 13F filing for Q2 2025, filed 6 Aug 2025.